Effectiveness and Safety of Weekly Semaglutide 2.0 mg Added to Lower vs Adjusted Insulin Glargine Doses in Overweight People with Type 2 Diabetes

Once-weekly semaglutide 2.0 mg in combination with dose-reduced insulin glargine may influence key health outcomes in Type 2 diabetes management.

• Comparing semaglutide plus reduced insulin to titrated insulin aims to assess effects on blood sugar levels.
• The study evaluates changes in glycated hemoglobin (HbA1c), a marker for long-term blood glucose control.
• Body weight may be affected by the combination treatment compared to traditional insulin dosing.
• Daily insulin dosage is analyzed to determine its relationship with the addition of semaglutide.
• Participant satisfaction is included as a measure of treatment acceptability.

Simplified